What does CUSIP 09077B104 represent in this 13F holders report?

CUSIP 09077B104 is the security identifier for BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share used to aggregate holder disclosures.

How many institutions held BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share in Q1 2023?

79 institutional investors reported BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share for Q1 2023. Use the holders table for investor-level position and value details.

BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB)

CUSIP: 09077B104

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class: Equity / Common Stocks, par value $0,0001 per share
Shares outstanding: 58,548,563
Total 13F shares: 32,818,307
Share change: -1,031,249
Total reported value: $87,622,240
Put/Call ratio: 98%
Price per share: $2.68
Number of holders: 79
Value change: -$35,920,780
Number of buys: 49
Number of sells: 41

Quarterly Holders Quick Answers

What is CUSIP 09077B104?
CUSIP 09077B104 identifies BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2023
Previous quarter: Q4 2022

Recent filing periods for CUSIP 09077B104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BCAB - BioAtla, Inc. - Common Stocks, par value $0,0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Soleus Capital Management, L.P.	13F	Company	7.2%	4,220,397	$34,818,275	—	31 Dec 2022	13F
Cormorant Asset Management, LP	13F	Company	6.3%	3,680,365	$30,363,000	—	31 Dec 2022	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	5.3%	3,124,076	$25,773,627	—	31 Dec 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	3.4%	1,982,841	$16,350,321	—	31 Dec 2022	13F
VANGUARD GROUP INC	13F	Company	3.3%	1,931,039	$15,931,072	—	31 Dec 2022	13F
MORGAN STANLEY	13F	Company	3.1%	1,821,364	$15,026,254	—	31 Dec 2022	13F
S.c.a. Candriam	13F	Individual	3.1%	1,805,406	$14,893,901	—	31 Dec 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	3%	1,750,000	$14,437,500	—	31 Dec 2022	13F
Avidity Partners Management LP	13F	Company	2.2%	1,260,000	$10,395,000	—	31 Dec 2022	13F
EcoR1 Capital, LLC	13F	Company	1.9%	1,124,439	$9,276,622	—	31 Dec 2022	13F
BlackRock Finance, Inc.	13F	Company	1.7%	1,015,203	$8,375,425	—	31 Dec 2022	13F
Boxer Capital, LLC	13F	Company	1.2%	686,347	$5,662,363	—	31 Dec 2022	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	1.1%	656,282	$5,414,327	—	31 Dec 2022	13F
Point72 Asset Management, L.P.	13F	Company	1.1%	649,680	$5,359,860	—	31 Dec 2022	13F
Vivo Capital, LLC	13F	Company	1.1%	637,181	$5,257,000	—	31 Dec 2022	13F
WASATCH ADVISORS LP	13F	Company	0.99%	578,976	$4,776,552	—	31 Dec 2022	13F
SILVERARC CAPITAL MANAGEMENT, LLC	13F	Company	0.93%	546,875	$4,511,719	—	31 Dec 2022	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.85%	500,000	$4,125,000	—	31 Dec 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.82%	479,400	$3,955,000	—	31 Dec 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.68%	398,619	$3,288,607	—	31 Dec 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.6%	352,297	$2,906,000	—	31 Dec 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.6%	349,200	$2,880,900	—	31 Dec 2022	13F
Guy Levy	3/4/5	Former Director	— class O/S missing	1,130,688	$2,781,493	—	16 Jun 2022	3/4/5
ORBIMED ADVISORS LLC	13F	Company	0.57%	332,372	$2,742,069	—	31 Dec 2022	13F
Laurion Capital Management LP	13F	Company	0.5%	292,600	$2,413,950	—	31 Dec 2022	13F
Oasis Management Co Ltd.	13F	Company	0.5%	289,855	$2,391,304	—	31 Dec 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.49%	288,992	$2,384,184	—	31 Dec 2022	13F
Opaleye Management Inc.	13F	Company	0.45%	261,800	$2,159,850	—	31 Dec 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.39%	227,725	$1,878,731	—	31 Dec 2022	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.32%	186,600	$1,539,450	—	31 Dec 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.28%	165,709	$1,368,000	—	31 Dec 2022	13F
Affinity Asset Advisors, LLC	13F	Company	0.26%	150,000	$1,237,500	—	31 Dec 2022	13F
Vontobel Holding Ltd.	13F	Company	0.25%	147,427	$1,216,273	—	31 Dec 2022	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.24%	138,294	$1,140,926	—	31 Dec 2022	13F
Endurant Capital Management LP	13F	Company	0.23%	136,382	$1,125,152	—	31 Dec 2022	13F
STATE STREET CORP	13F	Company	0.2%	119,606	$986,750	—	31 Dec 2022	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.18%	107,796	$889,317	—	31 Dec 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.17%	102,065	$842,000	—	31 Dec 2022	13F
Qube Research & Technologies Ltd	13F	Company	0.16%	94,348	$778,371	—	31 Dec 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.16%	93,050	$767,663	—	31 Dec 2022	13F
NORTHERN TRUST CORP	13F	Company	0.15%	85,383	$704,410	—	31 Dec 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.11%	66,543	$548,980	—	31 Dec 2022	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.11%	63,838	$526,664	—	31 Dec 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.1%	55,902	$461,191	—	31 Dec 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.09%	54,103	$446,000	—	31 Dec 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.08%	48,042	$396,346	—	31 Dec 2022	13F
Woodline Partners LP	13F	Company	0.08%	45,218	$373,049	—	31 Dec 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.08%	45,013	$371,000	—	31 Dec 2022	13F
CITIGROUP INC	13F	Company	0.07%	40,876	$337,227	—	31 Dec 2022	13F
MARSHALL WACE, LLP	13F	Company	0.07%	38,402	$316,818	—	31 Dec 2022	13F

Institutional Holders of BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) as of Q1 2023

As of 31 Mar 2023, BioAtla, Inc. - Common Stocks, par value $0,0001 per share (BCAB) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,818,307 shares. The largest 10 holders included Soleus Capital Management, L.P., ORBIMED ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., Candriam S.C.A., WASATCH ADVISORS LP, Cormorant Asset Management, LP, and BlackRock Inc.. This page lists 79 institutional shareholders reporting positions in this security for the Q1 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders

Q1 2023 holders

Holder diff

-9

Investor	Q4 2022 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q4 2022 Value $	Q1 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.